Biofrontera (BFRIW) Expected to Announce Quarterly Earnings on Wednesday

Biofrontera (NASDAQ:BFRIW – Get Free Report) is anticipated to announce its results before the market opens on Wednesday, November 18th. Analysts expect the company to announce earnings of ($0.22) per share and revenue of $8.25 million for the quarter.

Biofrontera Stock Performance

NASDAQ:BFRIW opened at $0.00 on Tuesday. The stock’s 50 day moving average price is $0.01 and its 200 day moving average price is $0.03. Biofrontera has a 52 week low of $0.00 and a 52 week high of $0.15.

Biofrontera Company Profile

(Get Free Report)

Biofrontera Inc. is a biopharmaceutical company focused on dermatology. It develops and commercializes treatments for sun-damaged skin and other conditions, with an emphasis on photodynamic therapy, which uses a light-sensitive medicine activated by a light source. Biofrontera Inc. became a separately traded U.S. company after its separation from Germany-based Biofrontera AG. BFRIW represents warrants associated with Biofrontera Inc., rather than the company’s common stock.

Featured Stories

Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.